Reporting Manager
Trails Edge Capital Partners, LP
Symbol
MIST
Shares outstanding
124,031,000 shares
Disclosed Ownership
5,333,333 shares
Ownership
4.3%
Form type
SCHEDULE 13G/A
Filing time
26 Mar 2026, 17:37:00 UTC
Date of event
20 Mar 2026
Previous filing
14 Nov 2025

Sponsored

Quoteable Key Fact

"Trails Edge Capital Partners, LP disclosed 4.3% ownership in Milestone Pharmaceuticals Inc. Common Shares (MIST) on 20 Mar 2026."

Quick Takeaways

  • Trails Edge Capital Partners, LP filed SCHEDULE 13G/A for Milestone Pharmaceuticals Inc. Common Shares (MIST).
  • Disclosed ownership: 4.3%.
  • Date of event: 20 Mar 2026.

What Changed

  • Previous schedule filing date: 14 Nov 2025.
  • Current filing was accepted on 26 Mar 2026, 17:37.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Trails Edge Capital Partners, LP 4.3% 5,333,333 5,333,333 0 By: Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP 4.3% 5,333,333 5,333,333 0 By: Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai 4.3% 5,333,333 5,333,333 0 /s/ Ortav Yehudai Ortav Yehudai / Individual